Page last updated: 2024-08-21

alpha-aminopyridine and Extranodal NK-T-Cell Lymphoma

alpha-aminopyridine has been researched along with Extranodal NK-T-Cell Lymphoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Chai, Y; Chen, B; Dong, M; Fang, H; Guo, RY; Li, N; Li, YX; Qi, F; Qi, SN; Song, YW; Wang, SL; Wei, YC; Yang, JL; Yang, Y; Zhang, D1
He, ZD; Hong, HY; Li, MW; Peng, ZG; Xu, QY; Yang, HY1
Chai, Y; Chen, B; Dong, M; Fang, H; Li, YX; Liu, WP; Liu, WX; Qi, F; Qi, SN; Song, YQ; Wang, WH; Wei, YC; Xie, Y; Zhang, CG; Zhang, D; Zheng, BM; Zhu, J1
Chen, B; Chen, J; Jiang, C; Lv, C; Wang, J; Xu, J; Xu, X1
Dong, M; Fan, Y; Feng, J; Hong, X; Huang, H; Ke, X; Li, W; Lu, X; Ning, Z; Qi, J; Shen, Z; Shi, Y; Yu, L; Zhang, W; Zhao, X; Zhou, D; Zhu, J1

Reviews

1 review(s) available for alpha-aminopyridine and Extranodal NK-T-Cell Lymphoma

ArticleYear
Sintilimab combined with chidamide in the treatment of extranodal nature killer/T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis: Two case reports and literature review.
    Medicine, 2022, Sep-23, Volume: 101, Issue:38

    Topics: Aminopyridines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Extranodal NK-T-Cell; Methylprednisolone; Oxaliplatin

2022

Trials

2 trial(s) available for alpha-aminopyridine and Extranodal NK-T-Cell Lymphoma

ArticleYear
First-Line Chemoradiation With or Without Chidamide (Tucidinostat) in Patients With Intermediate- and High-Risk Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma: A Randomized Phase 2 Study in China.
    International journal of radiation oncology, biology, physics, 2022, 07-15, Volume: 113, Issue:4

    Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chemoradiotherapy; Cisplatin; Humans; Killer Cells, Natural; Lymphoma, Extranodal NK-T-Cell; Middle Aged

2022
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8

    Topics: Adult; Aged; Aminopyridines; Antineoplastic Agents; Benzamides; Disease-Free Survival; Enteropathy-Associated T-Cell Lymphoma; Female; Histone Deacetylase Inhibitors; Humans; Leukopenia; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mycosis Fungoides; Neoplasm Recurrence, Local; Neutropenia; Skin Neoplasms; Thrombocytopenia; Treatment Outcome; Young Adult

2015

Other Studies

2 other study(ies) available for alpha-aminopyridine and Extranodal NK-T-Cell Lymphoma

ArticleYear
Intensive therapy can improve long-term survival in newly diagnosed, advanced-stage extranodal NK/T-cell lymphoma: A multi-institutional, real-world study.
    International journal of cancer, 2023, 11-01, Volume: 153, Issue:9

    Topics: Aminopyridines; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Prospective Studies; Retrospective Studies

2023
Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report.
    Medicine, 2021, Mar-12, Volume: 100, Issue:10

    Topics: Aminopyridines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Histone Deacetylase Inhibitors; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Nose Neoplasms; Programmed Cell Death 1 Receptor; Remission Induction; Treatment Outcome

2021